Literature DB >> 9806840

Chromosome localization and genomic structure of the KiSS-1 metastasis suppressor gene (KISS1).

A West1, P J Vojta, D R Welch, B E Weissman.   

Abstract

The identification and sequence of KiSS-1 (HGMW-approved symbol, KISS1), a human malignant melanoma metastasis-suppressor gene, was recently published. In this report, we present a corrected genomic sequence, genomic structure, and refined chromosomal location for KiSS-1. The genomic organization of the sequence reveals a gene consisting of four exons. The first two exons are not translated; the third exon contains 38 5' noncoding bases followed by the translational start site and another 100 translated bases. The terminal exon contains a further 332 translated bases, the translational stop codon, and the polyadenylation signal. The gene maps to chromosome 1q32 as determined by radiation hybrid mapping and FISH analysis. The relatively simple organization of this gene will facilitate analyses for mutations and abnormal expression in human tumors. Copyright 1998 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9806840     DOI: 10.1006/geno.1998.5566

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  53 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXVII. Kisspeptin receptor nomenclature, distribution, and function.

Authors:  Helen R Kirby; Janet J Maguire; William H Colledge; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

2.  An alternative transcription start site yields estrogen-unresponsive Kiss1 mRNA transcripts in the hypothalamus of prepubertal female rats.

Authors:  Juan Manuel Castellano; Hollis Wright; Sergio R Ojeda; Alejandro Lomniczi
Journal:  Neuroendocrinology       Date:  2014-03-28       Impact factor: 4.914

Review 3.  KiSS-1 and GPR54 as new players in gonadotropin regulation and puberty.

Authors:  Ursula B Kaiser; Wendy Kuohung
Journal:  Endocrine       Date:  2005-04       Impact factor: 3.633

Review 4.  The KISS1 metastasis suppressor: mechanistic insights and clinical utility.

Authors:  Kevin T Nash; Danny R Welch
Journal:  Front Biosci       Date:  2006-01-01

5.  KISS1 methylation and expression as predictors of disease progression in colorectal cancer patients.

Authors:  Shao-Qin Chen; Zhi-Hua Chen; Su-Yong Lin; Qi-Bao Dai; Leng-Xi Fu; Rui-Qing Chen
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

6.  Value of metastin receptor immunohistochemistry in predicting metastasis after radical nephrectomy for pT1 clear cell renal cell carcinoma.

Authors:  Sunao Shoji; Mayura Nakano; Tetsuro Tomonaga; Hakushi Kim; Kazuya Hanai; Yukio Usui; Yoshihiro Nagata; Masaki Miyazawa; Haruhiro Sato; Xian Yang Tang; Yoshiyuki Robert Osamura; Toyoaki Uchida; Toshiro Terachi; Koichi Takeya
Journal:  Clin Exp Metastasis       Date:  2013-01-01       Impact factor: 5.150

7.  MTSS1 is an independent prognostic biomarker for survival in intrahepatic cholangiocarcinoma patients.

Authors:  Wei Shi; Gulimire Hasimu; Yan Wang; Ning Li; Mingquan Chen; Hao Zhang
Journal:  Am J Transl Res       Date:  2015-10-15       Impact factor: 4.060

Review 8.  Kisspeptin signaling in the brain.

Authors:  Amy E Oakley; Donald K Clifton; Robert A Steiner
Journal:  Endocr Rev       Date:  2009-09-21       Impact factor: 19.871

9.  LC-MS/MS quantification of a neuropeptide fragment kisspeptin-10 (NSC 741805) and characterization of its decomposition product and pharmacokinetics in rats.

Authors:  Zhongfa Liu; Chen Ren; William Jones; Ping Chen; Stephanie B Seminara; Yee-Ming Chan; Nicola F Smith; Joseph M Covey; Jeffrey Wang; Kenneth K Chan
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2013-03-04       Impact factor: 3.205

10.  Systemic dissemination in cancer of unknown primary is independent of mutational inactivation of the KiSS-1 metastasis-suppressor gene.

Authors:  L Dova; V Golfinopoulos; G Pentheroudakis; I Georgiou; N Pavlidis
Journal:  Pathol Oncol Res       Date:  2008-03-20       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.